drugset / Trial / NCT01043276
A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study if to investiagte the time course of PF-00258210 plasma concentration in the presence or absence of PF-00610335 administered via oral inhalation using dry powder inhalers
Timeline
- Start
- 2010-01
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-00258210 | Unknown | 220 ug | Inhaled |
| Subject | PF-00258210 | Unknown | 350 ug | Inhaled |
| Subject | PF-00258210 | Unknown | 440 ug | Inhaled |
| Subject | PF-00610335 | Unknown | 450 ug | Inhaled |